The Specialty Pharmacist's Role in Optimizing Intravenous Immunoglobulin Use for Immune Disorder Treatment
0290-0000-18-070-H01-P
2.00
Clinical Utility of Pharmacokinetic Analysis in The Treatment of Hemophilia A: Assessing PK Parameters Beyond Half–Life
0290-0000-18-037-H01-P
This activity will focus on the role of the pharmacist when examining new extended half-life therapies for hemophilia A.
1.00
Specialty Pharmacy Considerations for Hemophilia Management
0290-0000-18-018-H01-P
This activity will examine the implications of hemophilia on a patient with regard to their quality of life and economic considerations.
1.00
An American Journal of Managed Care Symposium: Patient–Centered Management Strategies in Hemophilia
0290-0000-17-198-H01-P
The panel of this program will review the latest information regarding hemophilia, the importance of personalized therapy, and challenges associated with it.
1.50
Leveraging Pharmacist Expertise to Effectively Treat Hemophilia in Health Systems
0290-0000-17-201-H01-P
This 1.5 hour on-demand webcast from Pharmacy Times Continuing Education will focus on available and emerging treatment options for hemophilia.
1.50
Direct Oral Anticoagulants: Assessing Clinical and Economic Value
0290-0000-17-191-H01-P
3.00
An American Journal of Managed Care® Webinar: Value–Based Approaches in Hemophilia Management
0290-0000-17-184-H01-P
This activity will highlight the changing landscape of treatment and patient considerations to optimize outcomes in hemophilia.
1.00
Improving the Impact of Specialty Pharmacists in Hemophilia Management
0290-0000-17-114-H01-P
This PTCE program examines a multidisciplinary approach to hemophilia management to optimize patient care.
1.00